|
|
|
Volumn 4, Issue 2, 2005, Pages 110-116
|
|
Iron chelation therapy.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZOIC ACID DERIVATIVE;
DEFERASIROX;
DEFERIPRONE;
DEFEROXAMINE;
DRUG DERIVATIVE;
IRON CHELATING AGENT;
ISONIAZID;
PYRIDONE DERIVATIVE;
PYRIDOXAL;
PYRIDOXAL ISONICOTINOYL HYDRAZONE;
TRIAZOLE DERIVATIVE;
ARTICLE;
BETA THALASSEMIA;
BLOOD;
CHELATION THERAPY;
DRUG COMBINATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
IRON OVERLOAD;
MORTALITY;
ORAL DRUG ADMINISTRATION;
PHYSIOLOGY;
SURVIVAL;
TOXIC HEPATITIS;
ADMINISTRATION, ORAL;
BENZOIC ACIDS;
BETA-THALASSEMIA;
CHELATION THERAPY;
DEFEROXAMINE;
DRUG THERAPY, COMBINATION;
HEPATITIS, TOXIC;
HUMANS;
INFUSIONS, INTRAVENOUS;
IRON CHELATING AGENTS;
IRON OVERLOAD;
ISONIAZID;
PYRIDONES;
PYRIDOXAL;
SURVIVAL;
TRIAZOLES;
|
|
EID: 24944457520
PISSN: None
EISSN: 15410714
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (45)
|
|
References (0)
|
